World Adoptive T-Cell Therapy Summit


Curtis & Wyss Group is pleased to invite you to "World Adoptive T-Cell Therapy Summit" scheduled on May 29 - 30, 2017 in Lisbon, Portugal

By joining this summit of Curtis & Wyss Group, you will discuss and learn about the current issues on Adoptive T-Cell Therapy. This is an opportunity for thought leaders from biotech, big pharma, academia and the wider service community to discuss progress and share insight on strategies. This is a pivotal moment particularly because clinical progress has been made with Chimeric Antigen Receptors (CAR), T Cell Receptors (TCR), and Tumor Infiltrating Lymphocytes (TIL), making these therapies the frontrunner for curing immune-based diseases.

Key Practical Learning Points of the Summit:

  • Advancements in T-cell engineering
  • Efficacy in different cancer models
  • Results from human and clinical studies
  • Commercialization of Viable T-cell therapies
  • Scaling and manufacture of T-cells
  • Developing adoptive cell therapies for solid tumors
  • Clinical case studies on T cell receptors and their biology
  • Critical components needed to make adoptive T cell therapies viable
  • Advancements in T-cell engineering
  • Efficacy in different cancer models


Who should attend?

Chief Executives, Executive Directors, Vice Presidents, Heads, Team Leaders and Managers 

From Industries

  • Pharmaceutical,
  • Biotechnology,
  • Research Institutes, etc
  • Angenda with fill list of the speakers and all detailed information on our website

Building:not final
Address:not final
Return to overview